LENZ Therapeutics Inc. (LENZ)
NASDAQ: LENZ
· Real-Time Price · USD
38.69
0.84 (2.22%)
At close: Aug 18, 2025, 3:59 PM
38.51
-0.47%
After-hours: Aug 18, 2025, 07:55 PM EDT
2.22% (1D)
| Bid | 38.5 |
| Market Cap | 1.1B |
| Revenue (ttm) | 5.07M |
| Net Income (ttm) | -52.4M |
| EPS (ttm) | -1.63 |
| PE Ratio (ttm) | -23.74 |
| Forward PE | -13.66 |
| Analyst | Strong Buy |
| Ask | 39 |
| Volume | 682,305 |
| Avg. Volume (20D) | 409,290 |
| Open | 38.06 |
| Previous Close | 37.85 |
| Day's Range | 37.87 - 39.24 |
| 52-Week Range | 16.54 - 41.70 |
| Beta | 0.42 |
About LENZ
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol LENZ
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for LENZ stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
LENZ Therapeutics Inc. is scheduled to release its earnings on
Nov 5, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
9 months ago
+5.48%
LENZ Therapeutics shares are trading higher after ...
Unlock content with
Pro Subscription
10 months ago
-2.86%
LENZ Therapeutics shares are trading higher after the company announced the FDA accepted its new drug application for LNZ100 for the treatment of Presbyopia.
